Fasheng Li

Area of research

Pulmonary and Respiratory Medicine · Epidemiology

Research interest

Research focused on Adenocarcinoma and Autophagy, with related work in Homologous recombination, Lung cancer, Immune system. Notable publications include 'KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials', 'Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma', and 'Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma'.

h-index

—

citations

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Combining autophagy and immune characterizations to predict prognosis and therapeutic response in lung adenocarcinoma

Frontiers in Immunology 2022cited by 12position: middledoi

KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials

Frontiers in Oncology 2021cited by 27position: middledoi

Homologous recombination repair rathway and RAD54L in early-stage lung adenocarcinoma

PeerJ 2021cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Pulmonary and Respiratory Medicine · Epidemiology →